Covered recipient · General Payments record
JEFFREY NOEBELS
General Payments · PY2018–2024
$55,704.77
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,740.00 | 5 |
| Travel and Lodging | $1,632.86 | 3 |
| Food and Beverage | $155.19 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $2,242.22 | 6 |
| UCB SA | $2,240.00 | 4 |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920212022
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Company | $500.00 | 05/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135058968 | CMS |
| Eli Lilly and Company | $511.65 | 10/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135054278 | CMS |
| Eli Lilly and Company | $972.11 | 10/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135054280 | CMS |
| Eli Lilly and Company | $149.10 | 12/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135039371 | CMS |
| Eli Lilly and Company | $59.36 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135054098 | CMS |
| Eli Lilly and Company | $50.00 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135054100 | CMS |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150232391 | CMS |
| UCB SA | $420.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950435 | CMS |
| UCB SA | $840.00 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950441 | CMS |
| UCB SA | $420.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950437 | CMS |
| UCB SA | $560.00 | 11/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113950439 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.